Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of seven cases

Modern Pathology

Volumn 24, Issue 11, 2011, Pages 1421-1432

  Shao, Haipeng ^a,c   Xi, Liqiang ^a   Raffeld, Mark ^a   Feldman, Andrew L ^b   Ketterling, Rhett P ^b   Knudson, Ryan ^b   Rodriguez Canales, Jaime ^a   Hanson, Jeffrey ^a   Pittaluga, Stefania ^a   Jaffe, Elaine S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

CLL; dendritic cells; histiocytic sarcoma; laser capture microdissection; p53; transdifferentiation

Indexed keywords

CEBP BETA PROTEIN; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CHROMOSOME 17P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLONE; ELDERLY CARE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HISTIOCYTIC SARCOMA; HUMAN; IMMUNOGLOBULIN GENE; INTERDIGITATING DENDRITIC CELL SARCOMA; LASER CAPTURE MICRODISSECTION; LYMPHOCYTOMA; MALE; MORPHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; B-CELL-SPECIFIC ACTIVATOR PROTEIN; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL TRANSDIFFERENTIATION; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; DENDRITIC CELL SARCOMA, INTERDIGITATING; GENE REARRANGEMENT, B-LYMPHOCYTE; HISTIOCYTIC SARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LANGERHANS CELL SARCOMA; LASER CAPTURE MICRODISSECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MARYLAND; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; V(D)J RECOMBINATION;

EID: 80455155161     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.102     Document Type: Article

References (46)

1. Chao MP, Seita J, Weissman IL. Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb Symp Quant Biol 2008;73:439-449.
2. Jaffe ES, Harris NL, Stein H, et al. Introduction and overview of the classification of lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn, Vol., International Agency for Research on Cancer: Lyon, France, 2008, pp 158-166.
3. Young KH, Xie Q, Zhou G, et al. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event. Am J Clin Pathol 2008;129:157-166. (Pubitemid 352038604)
4. Kroft SH, Domiati-Saad R, Finn WG, et al. Precursor B-lymphoblastic transformation of grade I follicle center lymphoma. Am J Clin Pathol 2000;113:411-418. (Pubitemid 30217390)
5. Wang E, Hutchinson CB, Huang Q, et al. Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a 'transdifferentiation' during the clonal evolution. Leuk Lymphoma 2010;51:802-812.
6. Wang E, Papalas J, Hutchinson CB, et al. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual. Am J Surg Pathol 2011;35:457-463.
7. Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008;111: 5433-5439.
8. Zhang D, McGuirk J, Ganguly S, et al. Histiocytic/dendritic cell sarcoma arising from follicular lympho-ma involving the bone: a case report and review of literature. Int J Hematol 2009;89:529-532.
9. Baer MR, Krantz SB, Cousar JB, et al. Malignant histiocytoses developing in patients with B-cell lym-phomas. Report of two cases. Cancer 1986;57: 2175-2184. (Pubitemid 16121752)
10. Vasef MA, Zaatari GS, Chan WC, et al. Dendritic cell tumors associated with low-grade B-cell malignancies. Report of three cases. Am J Clin Pathol 1995;104: 696-701. (Pubitemid 26001447)
11. Wetzler M, Kurzrock R, Goodacre AM, et al. Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic type. Cancer 1995;76:609-617.
12. Alvaro T, Bosch R, Salvado MT, et al. True histiocytic lymphoma of the stomach associated with low-grade B-cell mucosa-associated lymphoid tissue (MALT)-type lymphoma. Am J Surg Pathol 1996;20:1406-1411. (Pubitemid 26367213)
13. Cossu A, Deiana A, Lissia A, et al. Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node. Arch Pathol Lab Med 2006;130:544-547.
14. Fraser CR, Wang W, Gomez M, et al. Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone. Am J Clin Pathol 2009;132:928-939.
15. Fend F, Emmert-Buck MR, Chuaqui R, et al. Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol 1999;154:61-66. (Pubitemid 29031612)
16. Eberle FC, Hanson JC, Killian JK, et al. Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn 2010;12:394-401.
17. Segal GH, Jorgensen T, Masih AS, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoprolifera-tive disorders of nonfollicular center cell type. Hum Pathol 1994;25:1269-1275. (Pubitemid 24378731)
18. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lym-phoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17: 2257-2317. (Pubitemid 38072572)
19. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007;23:2947-2948. (Pubitemid 350162903)
20. Brockman SR, Paternoster SF, Ketterling RP, et al. New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promye-locytic leukemia. Cancer Genet Cytogenet 2003;145: 144-151. (Pubitemid 36993746)
21. Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages. Cell 2004;117:663-676. (Pubitemid 38692531)
22. Cobaleda C, Busslinger M. Developmental plasticity of lymphocytes. Curr Opin Immunol 2008;20:139-148.
23. Bonetti F, Knowles III DM, Chilosi M, et al. A distinctive cutaneous malignant neoplasm expressing the Langerhans cell phenotype. Synchronous occurrence with B-chronic lymphocytic leukemia. Cancer 1985;55:2417-2425. (Pubitemid 15115193)
24. Gaertner EM, Tsokos M, Derringer GA, et al. Inter-digitating dendritic cell sarcoma. A report of four cases and review of the literature. Am J Clin Pathol 2001;115:589-597. (Pubitemid 32275952)
25. Laiosa CV, Stadtfeld M, Graf T. Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol 2006;24:705-738.
26. Rossi D, Cerri M, Capello D, et al. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 2008;142:202-215. (Pubitemid 351987315)
27. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
28. Okabe M, Otsu M, Ahn DH, et al. Definitive proof for direct reprogramming of hematopoietic cells to plur-ipotency. Blood 2009;114:1764-1767.
29. Ye Z, Zhan H, Mali P, et al. Human-induced pluripo-tent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009;114:5473-5480.
30. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
31. Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008;133:250-264. (Pubitemid 351508307)
32. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007;449:473-477. (Pubitemid 47509547)
33. Carotta S, Nutt SL. Losing B cell identity. Bioessays 2008;30:203-207. (Pubitemid 351341124)
34. Hagman J, Lukin K. Transcription factors drive B cell development. Curr Opin Immunol 2006;18:127-134. (Pubitemid 43328864)
35. Ramirez J, Lukin K, Hagman J. From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment. Curr Opin Immunol 2010;22:177-184.
36. Urbanek P, Wang ZQ, Fetka I, et al. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994;79:901-912. (Pubitemid 24371980)
37. Kallies A, Nutt SL. Terminal differentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol 2007;19:156-162. (Pubitemid 46357676)
38. Martins G, Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008;26:133-169. (Pubitemid 351600373)
39. Vicente-Duenas C, Gutierrez de Diego J, Rodriguez FD, et al. The role of cellular plasticity in cancer development. Curr Med Chem 2009;16:3676-3685.
40. Geissmann F, Manz MG, Jung S, et al. Development of monocytes, macrophages, and dendritic cells. Science 2010;327:656-661.
41. Dakic A, Wu L, Nutt SL. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol 2007;28:108-114. (Pubitemid 46283693)
42. Iwama A, Osawa M, Hirasawa R, et al. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J Exp Med 2002;195:547-558. (Pubitemid 34461500)
43. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001;412: 341-346. (Pubitemid 32691848)
44. Bassarova A, Troen G, Fossa A, et al. Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation. J Hematop 2009; 2:135-141.
45. Zenz T, Krober A, Scherer K, et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood 2008;112:3322-3329.
46. Zainuddin N, Murray F, Kanduri M, et al. TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia. Leuk Res 2011;35:272-274.